410.78
price up icon0.72%   2.93
after-market After Hours: 410.78
loading
Thermo Fisher Scientific Inc stock is traded at $410.78, with a volume of 3.01M. It is up +0.72% in the last 24 hours and down -2.03% over the past month. Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year end-2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (54%).
See More
Previous Close:
$407.85
Open:
$407.07
24h Volume:
3.01M
Relative Volume:
1.35
Market Cap:
$158.51B
Revenue:
$42.90B
Net Income/Loss:
$6.52B
P/E Ratio:
24.09
EPS:
17.05
Net Cash Flow:
$6.72B
1W Performance:
-2.17%
1M Performance:
-2.03%
6M Performance:
-25.55%
1Y Performance:
-28.39%
1-Day Range:
Value
$402.81
$415.75
1-Week Range:
Value
$402.81
$431.44
52-Week Range:
Value
$402.81
$627.88

Thermo Fisher Scientific Inc Stock (TMO) Company Profile

Name
Name
Thermo Fisher Scientific Inc
Name
Phone
(781) 622-1000
Name
Address
168 THIRD AVENUE, WALTHAM, MA
Name
Employee
125,000
Name
Twitter
@thermofisher
Name
Next Earnings Date
2024-10-23
Name
Latest SEC Filings
Name
TMO's Discussions on Twitter

Compare TMO with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
410.78 158.51B 42.90B 6.52B 6.72B 17.05
Diagnostics & Research icon
DHR
Danaher Corp
194.82 140.78B 23.82B 3.77B 4.90B 5.15
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
489.98 37.91B 3.93B 894.97M 837.70M 10.82
Diagnostics & Research icon
A
Agilent Technologies Inc
108.70 31.23B 6.53B 1.26B 1.31B 4.35
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
153.29 26.31B 15.41B 1.37B 2.11B 7.50

Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades

Date Action Analyst Rating Change
Jan-10-25 Upgrade Bernstein Mkt Perform → Outperform
Dec-23-24 Initiated Scotiabank Sector Perform
Oct-14-24 Initiated Redburn Atlantic Buy
Oct-01-24 Initiated Stephens Overweight
Aug-28-24 Initiated Wells Fargo Overweight
Jun-03-24 Resumed Jefferies Buy
Mar-18-24 Resumed Citigroup Neutral
Jan-24-24 Downgrade Barclays Overweight → Equal Weight
Jan-08-24 Downgrade Bernstein Outperform → Mkt Perform
Dec-18-23 Initiated HSBC Securities Buy
Dec-13-23 Initiated Wolfe Research Outperform
Oct-26-23 Downgrade KeyBanc Capital Markets Overweight → Sector Weight
Oct-25-23 Upgrade Wells Fargo Underweight → Equal Weight
Sep-28-23 Initiated Bernstein Outperform
Sep-06-23 Resumed Citigroup Buy
Jul-19-23 Initiated Raymond James Outperform
Jul-19-23 Reiterated Robert W. Baird Outperform
Jul-13-23 Upgrade Credit Suisse Neutral → Outperform
Apr-04-23 Reiterated Barclays Overweight
Dec-14-22 Initiated Deutsche Bank Buy
Dec-07-22 Initiated RBC Capital Mkts Outperform
Oct-27-22 Downgrade The Benchmark Company Buy → Hold
Aug-25-22 Initiated Credit Suisse Neutral
Apr-25-22 Downgrade Wells Fargo Equal Weight → Underweight
Jan-26-22 Resumed Barclays Overweight
Oct-20-21 Upgrade Citigroup Neutral → Buy
Oct-15-21 Resumed Cowen Outperform
Aug-05-21 Resumed Credit Suisse Outperform
Jul-16-21 Initiated The Benchmark Company Buy
Mar-18-21 Upgrade KeyBanc Capital Markets Sector Weight → Overweight
Mar-03-21 Initiated Barclays Overweight
Jan-08-21 Upgrade Credit Suisse Neutral → Outperform
Dec-16-20 Downgrade Citigroup Buy → Neutral
Dec-02-20 Initiated Goldman Buy
Nov-10-20 Initiated KeyBanc Capital Markets Sector Weight
Sep-30-20 Initiated Atlantic Equities Overweight
Sep-14-20 Initiated Morgan Stanley Overweight
Aug-20-20 Resumed JP Morgan Overweight
Jul-15-20 Upgrade Cleveland Research Neutral → Buy
Jul-07-20 Reiterated Needham Buy
Apr-23-20 Reiterated Needham Buy
Jan-31-20 Reiterated Needham Buy
Jan-22-20 Initiated Credit Suisse Neutral
Jan-08-20 Initiated Wells Fargo Equal Weight
Jan-07-20 Initiated Citigroup Buy
Nov-15-19 Initiated Stifel Buy
Jul-25-19 Reiterated Needham Buy
Jul-16-19 Downgrade Needham Strong Buy → Buy
May-30-19 Initiated Wolfe Research Outperform
May-23-19 Reiterated Needham Strong Buy
Apr-22-19 Reiterated Needham Strong Buy
Apr-16-19 Reiterated BofA/Merrill Buy
View All

Thermo Fisher Scientific Inc Stock (TMO) Latest News

pulisher
May 08, 2025

Digital Genome Market Forecast: Growth Trends, Key Players & - openPR.com

May 08, 2025
pulisher
May 08, 2025

Neuroendocrine Tumor Treatment Market: Investment Analysis & - openPR.com

May 08, 2025
pulisher
May 08, 2025

Tissue Diagnostics Market to Reach $12.4 Billion by 2029, Growing at 7.0% CAGR - GlobeNewswire Inc.

May 08, 2025
pulisher
May 08, 2025

Here's How Much You Would Have Made Owning Thermo Fisher Scientific Stock In The Last 20 Years - Benzinga

May 08, 2025
pulisher
May 08, 2025

Thermo Fisher Scientific Inc. (TMO): Among Billionaire Mario Gabelli’s Large-Cap Stock Picks with Huge Upside Potential - Yahoo Finance

May 08, 2025
pulisher
May 08, 2025

Engineer III, Manufacturing Engineering (Waltham, MA, USA) - The Chemical Engineer Job Board

May 08, 2025
pulisher
May 08, 2025

Thermo Fisher Scientific: 4 Reasons This Oversold Stock Is a Buy - Morningstar

May 08, 2025
pulisher
May 07, 2025

Custom Antibody Market To Hit USD 1,230.09 Billion By 2032 | - openPR.com

May 07, 2025
pulisher
May 07, 2025

High Content Screening Market Global Forecasts 2025-2030 - GlobeNewswire

May 07, 2025
pulisher
May 07, 2025

Smarter protection: New Class II biological safety cabinet - Labmate Online

May 07, 2025
pulisher
May 07, 2025

Thermo Fisher Scientific Inc. (TMO): Among Richard Chilton’s Stock Picks with Huge Upside Potential - Insider Monkey

May 07, 2025
pulisher
May 07, 2025

Thermo Fisher Scientific to Present at BofA Securities 2025 Health Care Conference on May 13 - BioSpace

May 07, 2025
pulisher
May 07, 2025

Thermo Fisher’s new biosafety cabinet offers improved lab safety and user experience - BioSpectrum Asia

May 07, 2025
pulisher
May 06, 2025

Oversold Conditions For Thermo Fisher Scientific (TMO) - Nasdaq

May 06, 2025
pulisher
May 06, 2025

Thermo Fisher Scientific Inc. stock falls Tuesday, underperforms market - MarketWatch

May 06, 2025
pulisher
May 06, 2025

Thermo Fisher CEO Marc Casper to Share Strategic Updates at Major Healthcare Conference - Stock Titan

May 06, 2025
pulisher
May 06, 2025

Benzyl Alcohol Market Scope: Growth, Share, Value, Size, - openPR.com

May 06, 2025
pulisher
May 05, 2025

Global Raman Spectroscopy Market Is Booming So Rapidly - openPR.com

May 05, 2025
pulisher
May 05, 2025

Immune Cell Engineering Market Generated Opportunities, - openPR.com

May 05, 2025
pulisher
May 05, 2025

Laboratory Equipment Market Future Business Opportunities - openPR.com

May 05, 2025
pulisher
May 05, 2025

Genome Engineering Market Generated Opportunities, Future - openPR.com

May 05, 2025
pulisher
May 04, 2025

Is Thermo Fisher Scientific (TMO) One of the Best Falling Stocks to Buy According to Analysts? - Insider Monkey

May 04, 2025
pulisher
May 03, 2025

Thermo Fisher Scientific to cut jobs at Orlando location - Yahoo Finance

May 03, 2025
pulisher
May 02, 2025

RoosterBio Announces Collaboration with Thermo Fisher Scientific to Advance Cell & Exosome Therapy Manufacturing - PRWeb

May 02, 2025
pulisher
May 02, 2025

THERMO FISHER SCIENTIFIC INC. SEC 10-Q Report - TradingView

May 02, 2025
pulisher
May 02, 2025

Epigenetics Market Is Booming So Rapidly 2025-2032 -Illumina - openPR.com

May 02, 2025
pulisher
May 02, 2025

Thermo Fisher Scientific Inc (TMO) Stock Analysis: A Closer Look at the 35.79% Potential Upside - DirectorsTalk Interviews

May 02, 2025
pulisher
May 02, 2025

RoosterBio announces collaboration with Thermo Fisher to advance cell therapy manufacturing - BioSpectrum Asia

May 02, 2025
pulisher
May 02, 2025

Thermo Fisher Scientific Leverages Integrated Solutions To Accelerate the Development of Biologic Therapeutics - Technology Networks

May 02, 2025
pulisher
May 02, 2025

RoosterBio and Thermo Fisher Scientific Agree to Collaborate to Advance Cell and Exosome Therapy Manufacturing - Genetic Engineering and Biotechnology News

May 02, 2025
pulisher
May 02, 2025

Lab Automation Market Set to Witness Significant Growth - openPR.com

May 02, 2025
pulisher
May 01, 2025

Thermo Fisher commits $2bn to boost US operations - The Manufacturer

May 01, 2025
pulisher
May 01, 2025

Thermo Fisher Scientific (NYSE:TMO) Collaborates With RoosterBio To Advance Cell Therapy Solutions - simplywall.st

May 01, 2025
pulisher
May 01, 2025

Thermo Fisher reports Q1 growth, charts a steady course for 2025 - BioProcess International

May 01, 2025
pulisher
May 01, 2025

Thermo Fisher Launches Improved Biological Safety Cabinet - Contract Pharma

May 01, 2025
pulisher
Apr 30, 2025

RoosterBio Announces Collaboration with Thermo Fisher Scientific to Advance Cell and Exosome Therapy Manufacturing - PR Newswire

Apr 30, 2025
pulisher
Apr 30, 2025

Research Grade Proteins Market to Witness Massive Growth by 2032 - openPR.com

Apr 30, 2025
pulisher
Apr 30, 2025

Thermo Fisher Scientific employs an enhanced platform technology - European Pharmaceutical Manufacturer

Apr 30, 2025
pulisher
Apr 30, 2025

Cell Lysis Market Growth in Future Scope 2025-2032 | Thermo - openPR.com

Apr 30, 2025
pulisher
Apr 29, 2025

Thermo Fisher Scientific Inc. (NYSE:TMO) Q1 2025 Earnings Call Transcript - MSN

Apr 29, 2025
pulisher
Apr 29, 2025

RoosterBio, Thermo Fisher Partner to Advance Cell & Exosome Therapy Manufacturing - Contract Pharma

Apr 29, 2025
pulisher
Apr 29, 2025

Thermo Fisher (TMO) Target Price Reduced by Argus | TMO Stock Ne - GuruFocus

Apr 29, 2025
pulisher
Apr 29, 2025

Thermo Fisher To Buy Phadia For $3.5 Billion - CHEManager Online

Apr 29, 2025
pulisher
Apr 29, 2025

Argus Adjusts Price Target on Thermo Fisher Scientific to $470 From $620 - marketscreener.com

Apr 29, 2025
pulisher
Apr 29, 2025

Thermo Fisher accelerates development of biologic therapeutics - BioSpectrum Asia

Apr 29, 2025
pulisher
Apr 29, 2025

Thermo Fisher Scientific Leverages Integrated Solutions to Accelerate the Development of Biologic Therapeutics - BioSpace

Apr 29, 2025
pulisher
Apr 29, 2025

Pharmacogenomics Market Detailed In New Research Report 2025 | - openPR.com

Apr 29, 2025
pulisher
Apr 29, 2025

Thermo Fisher Scientific to invest $2 billion to expand US operation - Indian Pharma Post

Apr 29, 2025
pulisher
Apr 29, 2025

ENCell and Thermo Fisher Scientific discuss expanded collaboration in cell and gene therapy field - koreabiomed.com

Apr 29, 2025
pulisher
Apr 28, 2025

Competent Cells Market Detailed in New Research Report By 2032 | - openPR.com

Apr 28, 2025
pulisher
Apr 28, 2025

Thermo Fisher Scientific Announces $2B Investment to Expand U.S. Operations - Thomasnet

Apr 28, 2025

Thermo Fisher Scientific Inc Stock (TMO) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
diagnostics_research DHR
$194.82
price up icon 0.90%
$489.98
price up icon 0.69%
diagnostics_research A
$108.70
price up icon 1.10%
diagnostics_research IQV
$153.29
price down icon 0.01%
$162.57
price up icon 1.54%
Cap:     |  Volume (24h):